ArticleInternational journal of hematology2022

Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors.

Yoriko Yamashita-Kashima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.